Cargando…
Aerosolized BC-819 Inhibits Primary but Not Secondary Lung Cancer Growth
Despite numerous efforts, drug based treatments for patients suffering from lung cancer remains poor. As a promising alternative, we investigated the therapeutic potential of BC-819 for the treatment of lung cancer in mouse tumor models. BC-819 is a novel plasmid DNA which encodes for the A-fragment...
Autores principales: | Hasenpusch, Günther, Pfeifer, Corinna, Aneja, Manish Kumar, Wagner, Kai, Reinhardt, Dietrich, Gilon, Michal, Ohana, Patricia, Hochberg, Avraham, Rudolph, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110766/ https://www.ncbi.nlm.nih.gov/pubmed/21687669 http://dx.doi.org/10.1371/journal.pone.0020760 |
Ejemplares similares
-
A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer
por: Lavie, Ofer, et al.
Publicado: (2017) -
Synthesis of the 8,19‐Epoxysteroid Eurysterol A
por: Taspinar, Ömer, et al.
Publicado: (2020) -
H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer
por: Sorin, Vladimir, et al.
Publicado: (2012) -
819. Experience with Isavuconazole Use for Treatment of Invasive Fungal Infections
por: Gow-Lee, Vanessa, et al.
Publicado: (2023) -
The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention
por: Matouk, Imad, et al.
Publicado: (2013)